Unicycive Therapeutics, Inc.

Direct answer

Unicycive Therapeutics, Inc. is publicly traded on NASDAQ under the ticker UNCY.

Unicycive Therapeutics, Inc. is a U.S.-based biotechnology company dedicated to the creation of innovative treatments for kidney diseases. Its development pipeline includes Renazorb, a therapy for hyperphosphatemia in chronic kidney disease patients, and UNI 494, which is being developed to treat acute kidney injury. Founded in 2016, the firm is headquartered in Los Altos, California.

Can you invest in Unicycive Therapeutics, Inc.?

Yes. Unicycive Therapeutics, Inc. trades publicly on NASDAQ as UNCY.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Unicycive Therapeutics, Inc.

Detailed equity research is provided by MarketSnap.